Spironolactone in Covid-19 Induced ARDS

The Effect of Spironolactone on Oxygenation in Covid-19 ARDS Patients

This study intended to evaluate the effects of commonly used diuretic, spironolactone, on oxygenation in covid-19 ARDS patients.

Inclusion Criteria:

• Hemodynamically stable
• Hypoxemia, i.e. p/f <150
• Admitted to ICU within 48 hours
• Not moribund has a life expectancy greater than 24 hours

Exclusion Criteria:

• Age criteria
• Pregnancy
• Unwillingness to participate